Innoviva INVA
NASDAQ INVA
$21.03 -0.25 (-1.17%)
As of: Oct 21, 2026 · 12:47 PM EDT

Innoviva (INVA) Acquisitions (2022)

Updated

Innoviva (INVA) posted Acquisitions of $23.07 million for FY2022.

Analysis

Innoviva (INVA) Acquisitions (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,133.15 Bn 1,101.73 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 616.41 Bn 534.94 Bn 17.26 Bn -17.24 Bn
3 AbbVie 501.01 Bn 474.12 Bn 12.70 Bn -
4 Merck 367.15 Bn 321.53 Bn 12.21 Bn -
5 Novartis Ag 298.00 Bn 261.99 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.56 Bn 235.25 Bn 12.86 Bn -
7 Amgen 235.40 Bn 190.80 Bn 7.24 Bn -
8 Gilead Sciences 190.38 Bn 164.57 Bn 6.22 Bn 11.21 Bn
9 Pfizer 169.76 Bn 116.40 Bn 10.94 Bn -
10 Innoviva 1.54 Bn -746.71 Mn 90.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -23.07 Mn
API Access

Innoviva Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=INVA&period=max&api_key=YOUR_API_KEY